NCIC

National Centre for Infections in Cancer - Improving patient outcomes through Infrastructure, Innovation and Implementation. Tweets by Prof Monica Slavin + team

[NCIC @NCICancer]

We’re proud to share that @benwteh has been appointed Honorary Clinical Professor with the Sir Peter MacCallum Department of Oncology, University of Melbourne

Please join us in congratulating Professor Teh on this well-deserved achievement!

[NCIC @NCICancer]

This week we said goodbye to our visiting fellow from Barcelona, Dr Pere Medina Martí, after a fantastic two-month visit with our team!
Pere joined us from Hospital Clínic de Barcelona via the group of previous visiting fellow and collaborator Dr Pedro Puerta.

[NCIC @NCICancer]

Join @SaferCareVic for a clinical conversation on assessing penicillin allergies, identifying low-risk cases, and understanding the testing process.
Tuesday, 5 May 2026
1:00 PM
Online
Presenters: Belinda Lambros & Rebecca Hall
Register🔗https://t.co/ncJZcQ4uDd

[NCIC @NCICancer]

Couldn’t join us for our guideline showcase?

Each chapter of the Australasian Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer | 2024 was presented by the corresponding author.

You can now watch the full recording: https://t.co/DxdZ7v1Bbe

[NCIC @NCICancer]

You are invited to attend a series of presentations on the Australasian Neutropenic Fever Guidelines 2024, delivered chapter by chapter by the guideline authors!

Join: https://t.co/EPi2mfvYvd

[NCIC @NCICancer]

We thank Dr. Rebekah Lane for visiting the NCIC as a two-week visiting fellow from Auckland City Hospital. We wish her all the best and look forward to welcoming her again, continuing to strengthen our collaboration with our colleagues in New Zealand!

[NCIC @NCICancer]

This week, Prof. Monica Slavin & Dr. Abby Douglas were invited guests at #Tandem26 (@ASTCT & @CIBMTR ) in Salt Lake City. Monica presented Challenging Cases in Transplant & Abby debated- Is Advanced Imaging in ID Worth the Cost? (“Con”).

[Peter Mac Cancer Centre @PeterMacCC]

50+ experts from Aus and NZ - incl. 20 from @PeterMacCC and @NCICancer - have delivered new guidelines for neutropenic fever in cancer care.

A multitdosciplinary collab that's shaping safer, more effective cancer care across the region.

Read more 👉 https://t.co/bfRIoNKOB7

[NCIC @NCICancer]

Recently published- updated Australasian guidelines for neutropenic fever in cancer patients!
✅ Includes paediatric recommendations for the first time
✅ Covers NZ
✅ New chapters on modern therapies, ambulatory care & patient engagement
Read here: https://t.co/x5lWLhLG6t

[NCIC @NCICancer]

Recently, @michyong2 presented at the 9th Annual #ICBMT2025 in Busan, Korea on CMV Infection in Allogeneic HSCT: Risk Stratification and Prevention, focused on advances in prophylaxis for CMV management after allogeneic hematopoietic stem cell transplantation- Congratulations!

[NCIC @NCICancer]

@martinhoenigl @TIMM_cc @eurconfmedmycol Great meeting and really fantastic to see lots of NCIC works mentioned by current and future collaborators. @c_garciavidal @FannyLanternier @michyong2 @monicaslavin

[NCIC @NCICancer]

Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group.

Read the full article here: https://t.co/4flhsDaXci

[Michelle Yong @michyong2]

🔥🔥Just published in #CID world-first clinical trial of IFN-a nasal spray vs placebo reduced #COVID 🦠 incidence 📉 by 40% in cancer pts. Well tolerated, safe, effective…

Full link here: https://t.co/Lds6PPpAya

[NCIC @NCICancer]

You're invited to the NCIC Showcase!

Learn about our work in infection & cancer care through rapid 2-min talks from clinicians, scientists & more.

📅 7 Aug | 🕧 12:30–2PM | 🏢 PMCC & Teams

🍽️ Lunch/tea included

🔗 Register: https://t.co/ZLXzw4VK23

[NCIC @NCICancer]

Join us for the Asia Fungal Working Group and @ASIDANZ 's ANZMIG Fungal Frontier Asia Pacific webinar on Emerging Dermatophyte Infections: Arrival of Antifungal Drug Resistance.

Date: 3rd of September
Time: 19.30 AEST
Location: Online

Register here: https://t.co/X0X5zjJVxz

[NCIC @NCICancer]

📰 July Newsletter is Out Now!

Catch up on the latest updates, research highlights, and upcoming events.

📖 Read it here: https://t.co/0bkAgZhMgD

[NCIC @NCICancer]

2 WEEKS AWAY
Join us Friday July 25 in Melbourne (or online!) for updates on Candida & other yeasts in clinical & lab diagnosis + deep dive into the Australasian Candidemia Study III.
Register: https://t.co/0SNsfBzDsK...

[NCIC @NCICancer]

We were proud to be well represented at the inaugural The @TSANZ_txsoc Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with @ASIDANZ
Immunocompromised Host Special Interest Group.

[NCIC @NCICancer]

@TheLancetInfDis

[NCIC @NCICancer]

Prof Monica Slavin - “Very pleased to be part of this important study of olorofim, a novel antifungal drug for difficult-to-treat fungal infections. It was active against infections resistant to or failing existing treatments and offers a much-needed option for our patients.”

[NCIC @NCICancer]

Read the article: https://t.co/TSuSyR2y1f